Boehringer Ingelheim: Christine Sakdalan and Mike Jablonski talk precision psychiatry

Power to the Patients

Apr 09 2025 | 00:40:32

00:00 / 00:40:32

Show Notes

In this episode of Power to the Patients, Boehringer Ingelheim leaders Christine Sakdalan and Mike Jablonski from discuss how precision psychiatry—using tools like biomarkers and neuroimaging—can personalize treatment for conditions like schizophrenia and depression. They highlight the importance of holistic care, digital therapeutics, and industry collaboration to address unmet needs and improve outcomes in mental health.

Other Episodes

Episode 1

September 19, 2024 • 00:38:43

Psychedelics and the Future of Anxiety Relief

In this episode, Dr. Dan Karlin, Chief Medical Officer at MindMed, talks about the potential of psychedelic therapies, especially LSD, to help treat anxiety....

Episode 6

December 06, 2024 • 00:49:46

A Pragmatic Approach to Psychedelic Drug Development

In this episode, Brandon Li sits down with Srinivas Rao, Co-CEO of atai Life Sciences, for a deep dive into the pragmatic strategies shaping...

Episode 14

February 25, 2025 • 00:45:01

Next-Gen Treatments for Anxiety and Depression Disorders

In this episode, Brandon sits down with Shawn Singh, CEO of Vistagen, to discuss a first-of-its-kind approach to treating mental health conditions. Vistagen is...